Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285676801> ?p ?o ?g. }
- W4285676801 abstract "Patients with severe hypertriglyceridaemia (sHTG) are often refractory to lipid-lowering therapy. Apolipoprotein (Apo) CIII inhibition could be promising to treat subjects with sHTG. The antisense oligonucleotide against APOC3 mRNA volanesorsen was recently introduced to treat sHTG. We performed a systematic review and meta-analysis of RCTs on the efficacy and safety of volanesorsen as compared to placebo treatment in patients with severe HTG.Studies were systematically searched in the PubMed, Web of Science and Scopus databases according to PRISMA guidelines. The last search was performed on 7 February 2022.Four studies showed significant reduction in TG after 3 months of treatment with volanesorsen as compared with placebo (MD: -73.9%; 95%CI: -93.5%, -54.2; p < .001 I2 = 89.05%; p < .001); VLDL-C level (MD: -71.0%; 95%CI: -76.6%, -65.4%; p < .001 I2 = 94.1%; p < .001); Apo-B48 level (MD: -69.03%; 95%CI: -98.59.4%, -39.47%; p < .001, I2 = 93.51%; p < .001) and Apo-CIII level (MD: -80.0%; 95%CI: -97.5%, -62.5; p < .001 I2 = 94.1%; p < .001) with an increase in HDL-C level (MD: +45.92%, 95%CI: +37.24%, +54.60%; p < .001 I2 = 94.34%; p < .001) and in LDL-C level (MD: +68.6%, 95%CI: +7.0%, +130.1%; p < .001 I2 = 96.18%; p < .001) without a significant elevation of Apo-B100 level (MD: +4.58%, 95%CI: -5.64%, +14.79%; p = .380 I2 = 95.09%; p < .001) in 139 volanesorsen patients as compared to 100 placebo-treated controls. Most of adverse events were mild and related to local injection site reactions.In patients with severe HTG, volanesorsen is associated with a significant reduction in TG, VLDL-C, Apo-B48 and non-HDL-C and increment of HDL-C as compared to placebo. Documented efficacy is accompanied by an acceptable safety profile." @default.
- W4285676801 created "2022-07-17" @default.
- W4285676801 creator A5001770956 @default.
- W4285676801 creator A5007516809 @default.
- W4285676801 creator A5053368792 @default.
- W4285676801 creator A5073001267 @default.
- W4285676801 date "2022-07-28" @default.
- W4285676801 modified "2023-10-13" @default.
- W4285676801 title "Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials" @default.
- W4285676801 cites W1924220480 @default.
- W4285676801 cites W1925850247 @default.
- W4285676801 cites W1988104806 @default.
- W4285676801 cites W1999504247 @default.
- W4285676801 cites W2005472296 @default.
- W4285676801 cites W2026031981 @default.
- W4285676801 cites W2032456325 @default.
- W4285676801 cites W2037283919 @default.
- W4285676801 cites W2052644460 @default.
- W4285676801 cites W2068700927 @default.
- W4285676801 cites W2077421021 @default.
- W4285676801 cites W2077657002 @default.
- W4285676801 cites W2098923148 @default.
- W4285676801 cites W2106784386 @default.
- W4285676801 cites W2114808162 @default.
- W4285676801 cites W2125012558 @default.
- W4285676801 cites W2125435699 @default.
- W4285676801 cites W2156098321 @default.
- W4285676801 cites W2159581689 @default.
- W4285676801 cites W2160942744 @default.
- W4285676801 cites W2169582126 @default.
- W4285676801 cites W2170009139 @default.
- W4285676801 cites W2315899065 @default.
- W4285676801 cites W2418001336 @default.
- W4285676801 cites W246286872 @default.
- W4285676801 cites W2588681363 @default.
- W4285676801 cites W2621005943 @default.
- W4285676801 cites W2767439026 @default.
- W4285676801 cites W2808484157 @default.
- W4285676801 cites W2809404316 @default.
- W4285676801 cites W2905774379 @default.
- W4285676801 cites W2957681909 @default.
- W4285676801 cites W2966503756 @default.
- W4285676801 cites W2969846379 @default.
- W4285676801 cites W3009316895 @default.
- W4285676801 cites W3010531939 @default.
- W4285676801 cites W3011963422 @default.
- W4285676801 cites W3013214255 @default.
- W4285676801 cites W3030043260 @default.
- W4285676801 cites W3045955397 @default.
- W4285676801 cites W3146122039 @default.
- W4285676801 cites W4200412236 @default.
- W4285676801 cites W4285676801 @default.
- W4285676801 cites W4294215472 @default.
- W4285676801 doi "https://doi.org/10.1111/eci.13841" @default.
- W4285676801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35851450" @default.
- W4285676801 hasPublicationYear "2022" @default.
- W4285676801 type Work @default.
- W4285676801 citedByCount "10" @default.
- W4285676801 countsByYear W42856768012022 @default.
- W4285676801 countsByYear W42856768012023 @default.
- W4285676801 crossrefType "journal-article" @default.
- W4285676801 hasAuthorship W4285676801A5001770956 @default.
- W4285676801 hasAuthorship W4285676801A5007516809 @default.
- W4285676801 hasAuthorship W4285676801A5053368792 @default.
- W4285676801 hasAuthorship W4285676801A5073001267 @default.
- W4285676801 hasBestOaLocation W42856768011 @default.
- W4285676801 hasConcept C126322002 @default.
- W4285676801 hasConcept C142424586 @default.
- W4285676801 hasConcept C142724271 @default.
- W4285676801 hasConcept C168563851 @default.
- W4285676801 hasConcept C204787440 @default.
- W4285676801 hasConcept C27081682 @default.
- W4285676801 hasConcept C2776919658 @default.
- W4285676801 hasConcept C2778163477 @default.
- W4285676801 hasConcept C2778913445 @default.
- W4285676801 hasConcept C62746215 @default.
- W4285676801 hasConcept C71924100 @default.
- W4285676801 hasConcept C86803240 @default.
- W4285676801 hasConcept C87355193 @default.
- W4285676801 hasConcept C90924648 @default.
- W4285676801 hasConcept C95190672 @default.
- W4285676801 hasConceptScore W4285676801C126322002 @default.
- W4285676801 hasConceptScore W4285676801C142424586 @default.
- W4285676801 hasConceptScore W4285676801C142724271 @default.
- W4285676801 hasConceptScore W4285676801C168563851 @default.
- W4285676801 hasConceptScore W4285676801C204787440 @default.
- W4285676801 hasConceptScore W4285676801C27081682 @default.
- W4285676801 hasConceptScore W4285676801C2776919658 @default.
- W4285676801 hasConceptScore W4285676801C2778163477 @default.
- W4285676801 hasConceptScore W4285676801C2778913445 @default.
- W4285676801 hasConceptScore W4285676801C62746215 @default.
- W4285676801 hasConceptScore W4285676801C71924100 @default.
- W4285676801 hasConceptScore W4285676801C86803240 @default.
- W4285676801 hasConceptScore W4285676801C87355193 @default.
- W4285676801 hasConceptScore W4285676801C90924648 @default.
- W4285676801 hasConceptScore W4285676801C95190672 @default.
- W4285676801 hasIssue "11" @default.
- W4285676801 hasLocation W42856768011 @default.
- W4285676801 hasLocation W42856768012 @default.
- W4285676801 hasLocation W42856768013 @default.